Get Retinoblastoma (Cancer of the Eye) Treatment Cost in India

Retinoblastoma (Cancer of the Eye) Treatment Cost in India

Cost

$ -

Procedure Type

Medical Management

Duration

44-180 Minutes

Hospitalization

3-7 Days

Stay in India

1-4 Weeks

Success Rate

98%

Overview

Retinoblastoma (Cancer of the Eye) treatment is affordable in India. The cost of Retinoblastoma (Cancer of the Eye) treatment in India lies between USD -. The exact procedure price depends on multiple factors such as the surgeon's experience, type of hospital, severity of the condition, patient's general condition, etc.

Top Doctors for Retinoblastoma (Cancer of the Eye) in India

About Procedure

Top Hospitals for Retinoblastoma (Cancer of the Eye) in India

Factor Affecting Cost

Risk & Benefits

Written by

Doctor of Pharmacy (PharmD)

Frequently Asked Questions

If detected early and surgically removed completely, bile duct cancer can be cured. For advanced cases, treatment aims to control the disease and improve quality of life.

 

Yes. With proper evaluation and supportive care, elderly patients can safely undergo surgery or chemo. India has age-tailored cancer care services.

It ranges from 5 to 10 days, depending on the complexity of the surgery and the patient’s recovery.

Yes. After recovery, Healzone facilitates follow-ups via video consultations with your Indian oncologist.

Yes. Standard chemotherapy protocols and medications are included, but targeted therapies may have additional charges based on the type used.

You need your passport, visa, recent medical reports (scans, biopsy), and any previous treatment history.

The entire surgery including cytoreduction and HIPEC typically lasts 6 to 10 hours, depending on the tumor’s complexity and extent.

HIPEC is not a guaranteed cure, but it significantly improves survival in select patients, especially when performed early and completely.

Most international patients can travel back after 2–3 weeks, once cleared by the surgical team and medically stable.

In some cases, additional systemic chemotherapy may be advised based on the final pathology report and disease risk.

You’ll need:
· Recent CT/MRI or PET-CT reports
· Biopsy/pathology report
· Blood test reports
· Medical summary (if available)

HIPEC is done under general anesthesia. Post-op pain is controlled with medications and improves within a few days.

Yes. Nutritionists provide personalized diet charts for recovery, focusing on high-protein, easily digestible foods.

Yes. Healzone offers interpreters for Arabic, French, Russian, Swahili, and more, ensuring clear communication throughout your treatment.

Immunotherapy is available for a wide range of cancers, but eligibility depends on molecular testing and cancer staging.

Yes. Indian hospitals use FDA and EMA-approved original immunotherapy drugs.

Usually 1–2 weeks per cycle. For long-term therapy, you can travel between cycles or stay continuously.

Yes, most patients can fly within 24–48 hours of each cycle unless advised otherwise.

If the resection is large, reconstructive surgery using tissue flaps may be performed to restore appearance and function.

Yes. Healzone gives you options based on budget, preferences, and availability.

Absolutely. Healzone arranges post-treatment video follow-ups and sends medical records electronically.

Yes, Indian hospitals use globally approved drugs, devices, and protocols.

No. All major hospitals have English-speaking staff and interpreters for Arabic, French, Swahili, and other languages.

Yes. Healzone arranges nearby hotels, serviced apartments, and customized meals for patients and families.

There is no minimum age. BMT is routinely performed for children as young as a few months in conditions like thalassemia or inherited immune disorders.

Yes. Parents are often haploidentical donors (50% match), and this type of transplant is increasingly successful due to new medical advancements.

You may need to stay for 6–8 weeks, including pre-transplant preparation, transplant, and immediate recovery with follow-up care.

GVHD is a known complication of allogeneic transplants but is manageable with immunosuppressants, steroids, and supportive therapies. Indian doctors are well-versed in treating it.

Patients stay in sterile isolation wards with HEPA filters, designed to prevent infection during the post-transplant immunocompromised period.
 

Yes. You can get initial HLA typing in your country and share results with Healzone for quicker donor coordination and planning.

You need a passport, recent photo, doctor’s referral, diagnosis report, and an invitation letter from the Indian treatment provider or Healzone.

Success rates range between 70% to 90%, depending on the disease, patient’s condition, and hospital protocols. India’s top BMT centers report international-standard outcomes.

Most international patients stay 4–6 weeks, including pre-transplant workup, stem cell harvesting, BMT procedure, and early post-discharge follow-up.

Most international patients stay 4–6 weeks, including pre-transplant workup, stem cell harvesting, BMT procedure, and early post-discharge follow-up.

No. In autologous BMT, your own stem cells are collected, stored, and used for transplant, eliminating the need for a donor.

Initial recovery (WBC/ANC normalization) takes 2–3 weeks. Full immune recovery and return to normal life may take 2–3 months.

Generally, patients below 65–70 years are preferred, but eligibility depends on fitness, heart/lung function, and disease stage—not just age.

A parent, child, or sibling who is 50% HLA matched can be a haploidentical donor. Most families can easily identify such a donor without relying on registries.
 
 

Pediatric BMTs may have slight variations in cost depending on disease severity and supportive needs, but the base transplant cost is similar.

India combines affordability, advanced infrastructure, and globally trained transplant doctors, offering world-class outcomes at a fraction of the Western cost.

The total stay is approximately 6 to 8 weeks, including pre-transplant evaluation, conditioning, transplant, and post-discharge follow-up.

PTCy is given to reduce the immune response that causes GVHD in half-match transplants. It is a key innovation in haploidentical BMT protocols globally.

Doctors may try a second infusion (if stem cells were cryopreserved) or use alternate salvage protocols. Failure is rare when pre-evaluation is thorough.
 

Bone marrow collection is done under anesthesia, so the donor feels no pain during the procedure. Discomfort, if any, is mild and temporary.

Packages typically include pre-transplant workup, donor stem cell collection, chemo, transplant, ICU care, post-op medications, and a few follow-up visits. Healzone ensures all inclusions are clearly listed.

Finding a 10/10 HLA matched unrelated donor may take 2 to 6 weeks depending on ethnicity, registry access, and donor responsiveness.

Yes, many hospitals evaluate haploidentical family donors as a backup while registry search is ongoing.

You’ll need to stay around 8 to 10 weeks, including workup, transplant, isolation, and early follow-up. Healzone helps with accommodation and care.

Yes, many patients return to school, work, and daily activities after 6–12 months, provided there’s no chronic GVHD or relapse.

India treats retinoblastoma, uveal melanoma, ocular lymphoma, and eyelid/orbital tumors, using global-standard methods.

Yes. India has extensive experience treating pediatric cancers like retinoblastoma, with specialized pediatric oncology teams.

Not necessarily. Many treatments aim to preserve vision, especially in early stages. Enucleation is only used when vision cannot be saved or tumor is life-threatening.

Many therapies, like plaque brachytherapy or laser, are minimally invasive. Surgery is done under anesthesia, and pain is well managed post-op.

After initial diagnosis (including imaging and biopsy), a multidisciplinary team in India will create a customized plan.

Yes. Most international patients return home after initial treatment and recovery (usually in 3–4 weeks), with virtual follow-ups.

Yes—early-stage adrenal cancer can be cured with complete surgical removal, often followed by mitotane therapy. Even in advanced stages, treatment can help reduce symptoms, slow progression, and improve quality of life. Success depends on tumor size, spread, and treatment timing.

The success rate of treatment varies by stage. For localized tumors, the 5-year survival rate can be 50–80%. India’s oncology centers offer survival rates comparable to Western standards due to early intervention, precise surgery, and affordable access to long-term therapy like mitotane.

If only one adrenal gland is removed, the remaining gland usually compensates. However, if both glands are affected, patients require lifelong steroid hormone replacement therapy, which is managed with endocrinology follow-up.

Yes. All standard regimens—including EDP (Etoposide, Doxorubicin, Cisplatin) and mitotane therapy—are available. Indian cancer centers follow NCCN and ESMO guidelines, and Healzone ensures access to approved and affordable medications.

While some adult patients do travel alone, it’s recommended to bring a companion for support during surgery and early recovery. Healzone offers on-ground assistance, companion accommodation, and medical interpreters if you’re traveling without family.

Long-term effects may include:

  • Fatigue from hormone imbalance
  • Weight changes or blood pressure fluctuations
  • Temporary immune suppression with chemotherapy

These are managed with regular checkups, hormone therapy, and lifestyle changes—India offers full post-treatment monitoring plans.